4.2 Article

The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy

Related references

Note: Only part of the references are listed.
Review Rheumatology

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009

D. E. Furst et al.

ANNALS OF THE RHEUMATIC DISEASES (2010)

Article Immunology

Nontuberculous Mycobacterial Disease Prevalence and Risk Factors: A Changing Epidemiology

P. Maureen Cassidy et al.

CLINICAL INFECTIOUS DISEASES (2009)

Article Rheumatology

Preventing and treating biologic-associated opportunistic infections

Kevin L. Winthrop et al.

NATURE REVIEWS RHEUMATOLOGY (2009)

Article Immunology

Nontuberculous Mycobacteria Infections and Anti-Tumor Necrosis Factor-α Therapy

Kevin L. Winthrop et al.

EMERGING INFECTIOUS DISEASES (2009)

Article Health Care Sciences & Services

Veteran's affairs hospital discharge databases coded serious bacterial infections accurately

Sebastian Schneeweiss et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)

Review Critical Care Medicine

An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

David E. Griffith et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Immunology

Antirheumatic drugs and the risk of tuberculosis

Paul Brassard et al.

CLINICAL INFECTIOUS DISEASES (2006)

Article Immunology

Pharmacy data for tuberculosis surveillance and assessment of patient management

DS Yokoe et al.

EMERGING INFECTIOUS DISEASES (2004)

Article Immunology

Granulomatous infectious diseases associated with tumor necrosis factor antagonists

RS Wallis et al.

CLINICAL INFECTIOUS DISEASES (2004)

Article Rheumatology

The epidemiology of rheumatoid arthritis

SE Gabriel

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2001)